BTG Share News (BTG)

WINNERS & LOSERS SUMMARY: Retailer Carpetright Rises On Fundraising

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------DS up 2.1%. to

LONDON MARKET MIDDAY: UK Wages In Line But Fail To Inspire Pound

LONDON (Alliance News) - Despite a lower open, the FTSE 100 was trading around its best levels since late January by midday on Tuesday as the latest UK wage data failed to inspire the pound.Rising in

BTG Swings To Annual Loss On PneumRx Coils Impairment Charges

LONDON (Alliance News) - BTG PLC on Tuesday swung to a pretax loss for the recently ended financial year due to a large impairment charge relating to PneumRx Coils, used to treat lung disease the

WINNERS & LOSERS SUMMARY: Vodafone Stumbles As CEO Stands Down

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 3.3%. The budget airline said it saw a first

LONDON MARKET OPEN: easyJet Rises While Vodafone Falls; UK Wages Due

LONDON (Alliance News) - The FTSE 100 was largely unchanged early Tuesday, with easyJet and Vodafone respectively topping and tailing the blue-chip index."In be

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 9 May Coca-Cola HBCQ1 ResultsIAGMay Traffic Statistics (at 1500 Year Year 10 11

BTG product gets two ticks of approval

(ShareCast News) - Global specialist healthcare company BTG announced the inclusion of treatment with its PneumRx Coils product in guidelines for the management of chronic obstructive pulmonary disease on Monday, as published by the Global Initiative for Chronic Obstructive Lung Disease (GOLD). The

BROKER RATINGS SUMMARY: Goldman And Deutsche Raise Miner Price Targets

WINNERS & LOSERS SUMMARY: Intermediate Capital And Polypipe Surge

BTG First Half Profit Slumps Due To Settlement And Currency Impact

Interventional medicine revenue surges at BTG

(ShareCast News) - Specialist healthcare company BTG posted its interim results for the six months to 30 September on Tuesday, with double-digit revenue growth underpinned by 24% constant exchange rate growth in interventional medicine revenues. The FTSE 250 firm said its operating profit for the pe

WINNERS & LOSERS SUMMARY: Standard Chartered Sold As Profit Misses

Wednesday broker round-up

(ShareCast News) - FirstGroup: Goldman Sachs keeps at buy with a target price of 168p. Esure: Berenberg stays at sell, 238p target. Anglo American: Deutsche Bank reiterates hold with a 965p target. Intertek: UBS reiterates buy with a 4100p target. Sainsbury: Goldman Sachs reiterates sell with a 1

BROKER RATINGS SUMMARY: Goldman Slightly Less Negative On UK Grocers

Clinigen Group Extends Exclusive Supply Agreement With BTG